Ovarian cancer has historically been called a “ silent killer ,” because clinicians thought its symptoms were undetectable. Patients were often diagnosed so late that doctors thought nothing could be ...

Mayo Clinic researchers have discovered a new immunotherapy target, a cryptic antigen, that may be key in helping the immune ...

The comparable rates of remission pre- and post-pandemic suggest that COVID-19 did not negatively impact the outcomes of ...

An NHS GP has shared that ovarian cancer 'worries' her the most because the symptoms are so obscure – as she said everyone ...

High heat shock protein 60 (HSP60) expression in patients with ovarian cancer is associated with larger tumors, advanced stages, and worse survival outcomes, highlighting its potential as a ...

Immunotherapy has changed the way physicians treat cancer patients. This approach to therapy targets the immune system to ...

A new immunotherapy target called a cryptic antigen may be key in helping the immune system fight ovarian cancer.

University of Virginia Cancer Center researchers have explained the failure of immune checkpoint therapy for ovarian cancer ...

Mayo Clinic researchers say because ovarian cancer has limited symptoms, it can go undetected until it has spread. At a later ...

Inspired by his close friend’s cancer journey, Nick Edwards will swim across Cook Strait in March to raise money for ovarian cancer. He speaks to the Herald’s Sarah Pollok ahead of the endeavour. A ...

Anixa Biosciences receives approval of protocol amendment for ovarian cancer CAR-T clinical trial: San Jose, California Friday, February 21, 2025, 18:00 Hrs [IST] Anixa Bioscience ...